Literature DB >> 26847621

Occurrence and predictors of recurrence after a first episode of acute venous thromboembolism: population-based Worcester Venous Thromboembolism Study.

Wei Huang1, Robert J Goldberg2, Frederick A Anderson3, Alexander T Cohen4, Frederick A Spencer5.   

Abstract

Venous thromboembolism (VTE) has multiple risk factors and tends to recur. Despite the benefits of anticoagulation, the prevalence of, and case-fatality rate associated with, recurrent VTE remains a concern after an acute episode; it is particularly high during the acute treatment phase. We sought to quantify the magnitude, identify predictors, and develop risk score calculator of recurrence within 3 years after first-time VTE. This was a population-based surveillance study among residents of central Massachusetts (MA), USA, diagnosed with an acute first-time pulmonary embolism and/or lower-extremity deep vein thrombosis from 1999 to 2009 in hospital and ambulatory settings in all 12 central MA hospitals. Medical records were reviewed and validated. The 2989 study patients were followed for 5836 person-years [mean follow-up 23.4 (median 30) months]. Mean age was 64.3 years, 44 % were men, and 94 % were white. The cumulative incidence rate of recurrent VTE within 3 years after an index VTE was 15 % overall, and 25, 13, and 13 % among patients with active cancer, provoked, or unprovoked VTE, respectively. Multivariable regression indicated that active cancer, varicose vein stripping, and inferior vena cava filter placement were independent predictors of recurrence during both 3-month and 3-year follow-up. A risk score calculator was developed based on the 3-month prognostic model. In conclusion, the rate of VTE recurrence over 3 years of follow-up remained high. The risk score calculator may assist clinicians at the index encounter in determining the frequency of clinical surveillance and appropriate outpatient treatment of VTE during the acute treatment phase.

Entities:  

Keywords:  Epidemiology; Predictors; Pulmonary embolism; Recurrence; Risk assessment; Venous thrombosis

Mesh:

Year:  2016        PMID: 26847621     DOI: 10.1007/s11239-015-1301-8

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  49 in total

1.  Predictors of venous thromboembolism recurrence, adjusted for treatments and interim exposures: a population-based case-cohort study.

Authors:  John A Heit; Brian D Lahr; Aneel A Ashrani; Tanya M Petterson; Kent R Bailey
Journal:  Thromb Res       Date:  2015-06-24       Impact factor: 3.944

2.  Clinical risk factors and timing of recurrent venous thromboembolism during the initial 3 months of anticoagulant therapy.

Authors:  J D Douketis; G A Foster; M A Crowther; M H Prins; J S Ginsberg
Journal:  Arch Intern Med       Date:  2000 Dec 11-25

3.  Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH).

Authors:  A Tosetto; A Iorio; M Marcucci; T Baglin; M Cushman; S Eichinger; G Palareti; D Poli; R C Tait; J Douketis
Journal:  J Thromb Haemost       Date:  2012-06       Impact factor: 5.824

4.  The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.

Authors:  Paolo Prandoni; Franco Noventa; Angelo Ghirarduzzi; Vittorio Pengo; Enrico Bernardi; Raffaele Pesavento; Matteo Iotti; Daniela Tormene; Paolo Simioni; Antonio Pagnan
Journal:  Haematologica       Date:  2007-02       Impact factor: 9.941

5.  Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism.

Authors:  Martha L Louzada; Marc Carrier; Alejandro Lazo-Langner; Vi Dao; Michael J Kovacs; Timothy O Ramsay; Marc A Rodger; Jerry Zhang; Agnes Y Y Lee; Guy Meyer; Philip S Wells
Journal:  Circulation       Date:  2012-06-07       Impact factor: 29.690

6.  Secular trends in occurrence of acute venous thromboembolism: the Worcester VTE study (1985-2009).

Authors:  Wei Huang; Robert J Goldberg; Frederick A Anderson; Catarina I Kiefe; Frederick A Spencer
Journal:  Am J Med       Date:  2014-05-06       Impact factor: 4.965

Review 7.  Venous thromboembolism: disease burden, outcomes and risk factors.

Authors:  J A Heit
Journal:  J Thromb Haemost       Date:  2005-08       Impact factor: 5.824

Review 8.  The epidemiology of venous thromboembolism.

Authors:  Richard H White
Journal:  Circulation       Date:  2003-06-17       Impact factor: 29.690

9.  Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis.

Authors:  Paolo Prandoni; Anthonie W A Lensing; Andrea Piccioli; Enrico Bernardi; Paolo Simioni; Bruno Girolami; Antonio Marchiori; Paola Sabbion; Martin H Prins; Franco Noventa; Antonio Girolami
Journal:  Blood       Date:  2002-07-12       Impact factor: 22.113

10.  Long-term death and recurrence in patients with acute venous thromboembolism: the MASTER registry.

Authors:  Melina Verso; Giancarlo Agnelli; Walter Ageno; Davide Imberti; Marco Moia; Gualtiero Palareti; Riccardo Pistelli; Valeria Cantone
Journal:  Thromb Res       Date:  2012-05-13       Impact factor: 3.944

View more
  6 in total

1.  Recurrent Deep Vein Thrombosis After the First Venous Thromboembolism Event: A Single-Institution Experience.

Authors:  Mohammad Asim; Hassan Al-Thani; Ayman El-Menyar
Journal:  Med Sci Monit       Date:  2017-05-20

2.  Obesity is not associated with recurrent venous thromboembolism in elderly patients: Results from the prospective SWITCO65+ cohort study.

Authors:  Carolin Mueller; Andreas Limacher; Marie Méan; Nicolas Rodondi; Drahomir Aujesky
Journal:  PLoS One       Date:  2017-09-15       Impact factor: 3.240

3.  A high Gas6 level in plasma predicts venous thromboembolism recurrence, major bleeding and mortality in the elderly: a prospective multicenter cohort study.

Authors:  Annatina Schnegg-Kaufmann; Sara Calzavarini; Andreas Limacher; Marie Mean; Marc Righini; Daniel Staub; Juerg-Hans Beer; Beat Frauchiger; Joseph Osterwalder; Nils Kucher; Christian M Matter; Marc Husmann; Martin Banyai; Markus Aschwanden; Lucia Mazzolai; Oliver Hugli; Michael Nagler; Michael Daskalakis; Nicolas Rodondi; Drahomir Aujesky; Anne Angelillo-Scherrer
Journal:  J Thromb Haemost       Date:  2019-02       Impact factor: 5.824

4.  Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP).

Authors:  Jasmijn F Timp; Sigrid K Braekkan; Willem M Lijfering; Astrid van Hylckama Vlieg; John-Bjarne Hansen; Frits R Rosendaal; Saskia le Cessie; Suzanne C Cannegieter
Journal:  PLoS Med       Date:  2019-10-11       Impact factor: 11.069

Review 5.  Predicting the risk of recurrent venous thrombosis: What the future might bring.

Authors:  Willem M Lijfering; Jasmijn F Timp; Suzanne C Cannegieter
Journal:  J Thromb Haemost       Date:  2019-07-16       Impact factor: 5.824

6.  Incident thrombus location and predicting risk of recurrent venous thromboembolism.

Authors:  Sara C Lidstrom; Kerri L Wiggins; Laura B Harrington; Barbara McKnight; Marc Blondon; Nicholas L Smith
Journal:  Res Pract Thromb Haemost       Date:  2022-07-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.